LAGHI PASINI, FRANCO
 Distribuzione geografica
Continente #
NA - Nord America 12.710
EU - Europa 9.950
AS - Asia 4.568
SA - Sud America 855
AF - Africa 110
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 28.224
Nazione #
US - Stati Uniti d'America 12.589
GB - Regno Unito 2.459
RU - Federazione Russa 1.957
CN - Cina 1.926
SG - Singapore 1.413
IE - Irlanda 1.384
SE - Svezia 840
UA - Ucraina 816
IT - Italia 748
BR - Brasile 739
DE - Germania 728
FR - Francia 441
HK - Hong Kong 369
FI - Finlandia 275
KR - Corea 234
VN - Vietnam 230
IN - India 106
CA - Canada 78
ES - Italia 65
TR - Turchia 59
NL - Olanda 47
BE - Belgio 38
PL - Polonia 36
AR - Argentina 35
CI - Costa d'Avorio 35
JP - Giappone 32
BD - Bangladesh 25
EC - Ecuador 25
MX - Messico 25
CZ - Repubblica Ceca 23
ZA - Sudafrica 22
AT - Austria 21
IQ - Iraq 21
PK - Pakistan 20
TH - Thailandia 20
MA - Marocco 17
VE - Venezuela 15
AU - Australia 13
LT - Lituania 13
GR - Grecia 12
UZ - Uzbekistan 12
EU - Europa 11
IL - Israele 10
KZ - Kazakistan 10
SA - Arabia Saudita 10
AZ - Azerbaigian 9
CO - Colombia 9
ID - Indonesia 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
IR - Iran 7
JO - Giordania 7
KE - Kenya 7
TN - Tunisia 7
BO - Bolivia 6
CL - Cile 6
EG - Egitto 6
LV - Lettonia 6
NP - Nepal 6
PE - Perù 6
BG - Bulgaria 5
JM - Giamaica 5
PY - Paraguay 5
RO - Romania 5
UY - Uruguay 5
HR - Croazia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
AL - Albania 3
BB - Barbados 3
CY - Cipro 3
ET - Etiopia 3
KG - Kirghizistan 3
OM - Oman 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GY - Guiana 2
NG - Nigeria 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CH - Svizzera 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GF - Guiana Francese 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KW - Kuwait 1
Totale 28.208
Città #
Southend 2.233
Fairfield 1.488
Dallas 1.411
Dublin 1.355
Ashburn 1.022
Singapore 798
Chandler 734
Woodbridge 691
Jacksonville 643
Wilmington 574
Santa Clara 562
Moscow 546
Menlo Park 539
Seattle 536
Houston 533
Beijing 522
Cambridge 470
Ann Arbor 397
Hong Kong 366
Siena 316
Princeton 266
Nanjing 232
Seoul 232
Hefei 231
New York 161
Los Angeles 127
Boardman 118
Dearborn 113
Dong Ket 111
Munich 110
Helsinki 106
The Dalles 103
San Diego 96
San Mateo 92
Buffalo 90
Nanchang 85
São Paulo 62
Shanghai 61
Shenyang 60
Council Bluffs 57
Florence 46
Málaga 46
Columbus 45
Ho Chi Minh City 44
Tianjin 44
Düsseldorf 40
Hebei 40
Turku 39
Venezia 39
Brussels 38
Kunming 37
Milan 37
Abidjan 35
San Francisco 35
Changsha 33
Redondo Beach 33
Jiaxing 32
Brooklyn 29
Lancaster 29
London 29
Jinan 28
Warsaw 28
Chicago 26
Guangzhou 26
Izmir 26
Bengaluru 25
Hanoi 25
Toronto 25
Montreal 24
Norwalk 24
Tokyo 24
Rio de Janeiro 22
Falls Church 21
Ankara 20
Poggiomarino 20
Zhengzhou 20
Belo Horizonte 19
Phoenix 19
Washington 19
Lappeenranta 18
Atlanta 17
Johannesburg 17
Boston 16
Denver 16
Mestre 16
Nuremberg 16
Orem 16
Redwood City 16
Rome 16
Ningbo 15
Amsterdam 14
Chennai 13
Frankfurt am Main 13
Hangzhou 13
Poplar 13
Pune 13
Almere Stad 12
Changchun 11
Guayaquil 11
Lanzhou 11
Totale 19.743
Nome #
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 370
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system 368
Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 368
Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 358
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 330
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 324
Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation 315
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 310
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 299
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 295
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 288
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 286
Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease 281
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 279
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis 274
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 269
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 266
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 263
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 261
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 256
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 254
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 237
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 237
Torsades de Pointes in patients with polymyalgia rheumatica 235
Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats 233
QTc interval prolongation during infusion with dipyridamole or adenosine 232
Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs 228
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 223
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 223
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 222
The role of P2X7 receptors in tissue fibrosis: a brief review 222
Isolated atrioventricular block of unknown origin in the adult and autoimmunity: Diagnostic and therapeutic considerations exemplified by 3 anti-Ro/SSA-associated cases 222
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 221
Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: Clinical evidence and molecular mechanisms 221
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls 221
Heart failure and chronic kidney disease in a registry of internal medicine wards 220
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 218
Alteration in the redox state of plasma in heart transplanted patients with moderate hyperhomocisteinemia 217
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 216
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients 214
Statins and the joint: multiple targets for a global protection? 214
Simvastatin inhibits T cell activation by selectively impairing the function of RAS superfamily GTPases 213
Cytokine production from peripheral mononuclear cells in 2 patients affected by adrenomyeloneuropathy 211
Connective tissue diseases and cardiac rhythm disorders: an overview 208
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 208
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 206
Human rheumatoid synoviocytes express functional P2X7 receptors 206
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 205
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 204
Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses 204
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 202
The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols 201
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 198
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation. 198
T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives 197
Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders 197
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. 196
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 196
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series 195
Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis 195
Adenosine A2(A) receptor gene polymorphism (1976C > T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy 191
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 191
Psychosine-induced apoptosis and cytokine activation in immune peripheral cells of Krabbe patients. 190
Modulation of P2X7 receptor during inflammation in multiple sclerosis 190
Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids 189
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans 187
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. 186
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: Clinical evidence, putative mechanisms, and therapeutic implications 185
Pathogenesis of the novel autoimmune-associated long-QT syndrome 181
Evidence of an adenosine-dependent mechanism in the hypotensive effect of L-arginine in man 180
Using peripheral blood mononuclear cells to determine proteome profiles in human cardiac failure 180
Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias 180
Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates 179
Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease 177
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts 176
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 176
Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad 174
Familial Mediterranean fever diagnosed in an elderly patient 173
The "Invulnerability" of the Adult Conduction System to Anti-Ro/SSA Antibodies? A Matter of Calcium Channel Expression on the Cardiomyocyte 172
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 171
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 170
Haemodynamics, rheology and mechanism of action of iloprost in man 170
Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: a possible role for platelet activation 169
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation 169
Peripheral neuropathy associated with ischemic vascular disease of the lower limbs 166
Variazioni diurne dell’ effetto anticoagulante dell’ eparina non frazionata in corso di infusione continua e.v. nell’ uomo. Modificazioni indotte da acido acetlsalicico per os 164
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 164
Enhanced apoptosis of peripheral blood mononuclear cells (PBMC) in cardiac transplanted patients undergoing chronic immunosuppressive treatment 163
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 162
ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family 162
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 162
Effect ofthymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study. arthritis patients. -I) In vitro study 162
Homocysteine and Raynaud’s phenomenon: a review 162
Photopheresis immunomodulation after heart transplantation. 161
Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities 159
Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk 158
Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. 158
Effects ofthymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoidarthritis patients.-II) In vivo study 157
Simvastatin reduces MMP-3 level in interleukin 1b-stimulated human chondrocyte culture 156
Long QT Syndrome: An Emerging Role for Inflammation and Immunity 155
Totale 21.507
Categoria #
all - tutte 87.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.855 0 0 0 0 0 348 111 375 287 262 230 242
2021/20222.075 147 273 129 173 135 58 103 105 113 180 206 453
2022/20232.706 168 243 394 385 245 546 70 191 289 64 61 50
2023/20242.205 98 31 168 103 103 632 720 57 22 51 55 165
2024/20253.944 74 207 350 248 514 238 131 216 317 175 449 1.025
2025/20266.120 763 1.369 940 1.063 1.890 95 0 0 0 0 0 0
Totale 28.499